Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Anticancer Research|June 10, 2019
Optimal Timing of Cabazitaxel Introduction for Japanese Patients With Metastatic Castration-resistant Prostate CancerToshiki Ito, Kent Kanao, Kiyoshi Takahara, et al.Journal of Endourology Case Reports|October 26, 2020
Dorsal Vein Complex Preserving Technique During Robot-Assisted Radical ProstatectomyKent Kanao, Hiroyuki Muramatsu, Shingo Morinaga, et al.Urologic Oncology|September 22, 2020
Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapyKeita Tamura, Ryosuke Ando, Kiyoshi Takahara, et al.Japanese Journal of Clinical Oncology|August 2, 2019
Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancerKent Kanao, Toshiki Ito, Kiyoshi Takahara, et al.The Journal of Urology|September 6, 2006
Preoperative nomograms for predicting stone-free rate after extracorporeal shock wave lithotripsyKent Kanao, Jun Nakashima, Ken Nakagawa, et al.The Journal of Urology|December 23, 2008
Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classificationKent Kanao, Ryuichi Mizuno, Eiji Kikuchi, et al.Anticancer Research|July 31, 2020
Prognostic Stratification of the IMDC Intermediate Risk Group After Treatment With First-line Molecular-targeted Therapy for Metastatic Renal Cell CarcinomaKiyoshi Takahara, Ryosuke Ando, Kent Kanao, et al.International Cancer Conference Journal|July 4, 2024
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case reportYusuke Hoshino, Kent Kanao, Yu Miyama, et al.Japanese Journal of Clinical Oncology|July 20, 2012
Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinomaKenjiro Suzuki, Ryuichi Mizuno, Shuji Mikami, et al.Japanese Journal of Clinical Oncology|July 18, 2014
Individualized prostate-specific antigen threshold values to avoid overdiagnosis of prostate cancer and reduce unnecessary biopsy in elderly menKent Kanao, Osamu Komori, Jun Nakashima, et al.Pageof 8